Gary W Pace's Net Worth

$33.7 Million

Estimate Recalculated Nov 11, 2024 07:45AM EST

Who is Gary W Pace

Gary W Pace has an estimated net worth of $33.7 Million. This is based on reported shares across multiple companies, which include PEPLIN INC, Pacira BioSciences, Inc., Cardiff Oncology, Inc., RESMED INC, and Imunon, Inc..

SEC CIK

Gary W Pace's CIK is 0001184778

Past Insider Trading and Trends

2008 was Gary W Pace's most active year for acquiring shares with 17 total transactions. Gary W Pace's most active month to acquire stocks was the month of May. 2022 was Gary W Pace's most active year for disposing of shares, totalling 7 transactions. Gary W Pace's most active month to dispose stocks was the month of February. 2011 saw Gary W Pace paying a total of $5,708,916.40 for 297,095 shares, this is the most they've acquired in one year. In 2018 Gary W Pace cashed out on 56,806 shares for a total of $2,765,600.11, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PEPLIN INC

Investor
Updated Dec 04, 2008
Form 4
18.47%
3.28K
$3.85
$12.61K
Dec 04, 2008
21.03K
Purchase
Dec 02 - Dec 03
Form 4
91.89%
8.50K
$3.90
$33.16K
Dec 02, 2008
17.75K
Purchase
Nov 28 - Dec 01
Form 3
Oct 30, 2008
9.25K
Showing 3 results

Pacira BioSciences, Inc.

Investor
Updated Mar 08, 2024
Form 4
-84.36%
-119.32K
$30.64
-$3.66M
Mar 08, 2024
22.13K
Sale
Mar 06 - Mar 08
Form 4
10.52%
14.70K
Jun 16, 2023
154.38K
Grant
Jun 14
Form 4
-3.47%
-5.01K
$35.84
-$226.70
May 15, 2023
139.68K
Sale
May 11
Form 4
6.87%
9.38K
Jun 08, 2022
145.92K
Grant
Jun 08
Form 4
$10.81
$75.67K
Mar 07, 2022
136.53K
Options
Mar 03
Form 4
-18.65%
-30.00K
$38.95
-$1.68M
Mar 01, 2022
130.89K
Sale
Feb 28 - Mar 01
Form 4
5.55%
7.21K
Jun 11, 2021
137.16K
Grant
May 13 - Jun 09
Form 4
$16.67
$1.17M
Sep 29, 2020
129.95K
Options
Sep 25
Form 4
15.82%
9.29K
Jun 11, 2020
67.98K
Grant
Jun 09
Form 4
$4.46
$96.84K
Mar 16, 2020
58.69K
Options
Mar 12
Form 4
38.30%
12.57K
Jun 06, 2019
45.39K
Grant
Jun 05
Form 4
15.89%
4.50K
$46.18
$207.81K
Nov 21, 2018
32.82K
Purchase
Nov 19
Form 4
16.45%
4.00K
$51.29
$205.16K
Nov 09, 2018
28.32K
Purchase
Nov 07
Form 4
23.26%
5.47K
Jun 15, 2018
29.01K
Grant
Jun 13
Form 4
18.35%
4.07K
Jun 16, 2017
26.25K
Grant
Jun 14
Form 4
21.57%
4.46K
Jun 17, 2016
25.16K
Grant
Jun 15
Form 4
32.10%
6.00K
Jun 05, 2015
24.69K
Grant
Jun 03
Form 4
5.65%
1.00K
$93.83
$93.83K
Mar 17, 2015
18.69K
Purchase
Mar 13
Form 4
8.00K
Jun 05, 2014
8.00K
Grant
Jun 03
Form 4
7.00K
Jun 14, 2013
7.00K
Grant
Jun 12
Form 4
70.00K
Aug 21, 2012
70.00K
Grant
Aug 17
Form 4
7.00K
Jun 07, 2012
7.00K
Grant
Jun 05
Form 4
130.01%
10.00K
$9.75
$97.50K
Apr 17, 2012
17.69K
Purchase
Apr 17
Form 4
30.00K
Apr 05, 2012
30.00K
Grant
Apr 03
Form 4
7.69K
$6.50
$50.00K
Nov 23, 2011
7.69K
Purchase
Nov 21
Form 4
5.00K
Jun 06, 2011
5.00K
Grant
Jun 02
Form 3
Feb 02, 2011
Showing 27 results

Cardiff Oncology, Inc.

Investor
Updated Jul 01, 2024
Form 4
25.33%
29.70K
Jul 01, 2024
146.97K
Grant
Jun 27
Form 4
4.49%
30.00K
$1.37
$41.10K
Dec 19, 2023
697.76K
Purchase
Dec 19
Form 4
3.56%
22.95K
$0.98
$22.49K
Nov 14, 2023
667.76K
Purchase
Nov 10
Form 4
30.92%
27.70K
Jun 20, 2023
117.27K
Grant
Jun 15
Form 4
30.31%
150.00K
$1.71
$256.50K
Sep 19, 2022
644.81K
Purchase
Sep 15
Form 4
42.69%
26.80K
Mar 11, 2022
89.57K
Grant
Mar 09
Form 4
6.45%
30.00K
$6.75
$202.50K
Sep 22, 2021
494.81K
Purchase
Sep 21
Form 4
53.96%
22.00K
Jun 14, 2021
62.77K
Grant
Jun 10
Form 4
2.20%
10.00K
$10.23
$102.30K
Mar 24, 2021
464.81K
Purchase
Mar 23
Form 4
0.66%
3.00K
$10.55
$31.66K
Mar 19, 2021
454.81K
Purchase
Mar 18
Form 4
0.33%
1.50K
$9.27
$13.90K
Mar 04, 2021
451.81K
Purchase
Mar 04
Form 4
0.57%
2.55K
$5.70
$14.53K
Sep 17, 2020
450.31K
Purchase
Sep 16
Form 4
242.18%
28.86K
Jun 19, 2020
40.77K
Grant
Jun 17
Form 4
447.76K
$1.34
$600.00K
May 13, 2020
447.76K
Purchase
May 11
Form 4
11.92K
May 01, 2020
11.92K
Grant
Apr 16
Form 3
Apr 22, 2020
Showing 16 results

RESMED INC

Investor
Updated May 10, 2018
Form 4
-22.02%
-28.40K
$62.48
-$1.98M
May 10, 2018
100.58K
Sale
May 08
Form 4
3.06%
2.99K
Nov 17, 2017
100.58K
Grant
Nov 16
Form 4
-20.00%
-24.39K
$54.85
-$1.03M
Jun 16, 2017
97.59K
Sale
ScheduledJun 14 - Jun 15
Form 4
4.75%
4.43K
Nov 17, 2016
97.59K
Grant
Nov 16
Form 4
-27.87%
-36.00K
$47.74
-$1.60M
Aug 22, 2016
93.16K
Sale
Aug 19
Form 4
-27.87%
-36.00K
$41.94
-$1.30M
Mar 14, 2016
93.16K
Sale
ScheduledMar 11
Form 4
20.49K
Nov 23, 2015
113.65K
Grant
Nov 19
Form 4
-34.00%
-48.00K
$41.64
-$2.41M
Jan 28, 2015
93.16K
Sale
Jan 26
Form 4
4.88K
Nov 21, 2014
93.16K
Grant
Nov 19
Form 4
-22.07%
-25.00K
$36.32
-$533.15K
Aug 20, 2014
88.27K
Sale
Aug 18
Form 4
-38.32%
-48.00K
$29.40
-$1.60M
Feb 20, 2014
77.27K
Sale
Feb 18
Form 4
20.71K
Nov 15, 2013
97.99K
Grant
Nov 13
Form 4
13.44%
12.00K
$36.57
$877.75K
Sep 11, 2013
77.27K
Sell-Options
ScheduledSep 09
Form 4
25.93K
Nov 19, 2012
103.21K
Grant
Nov 15
Form 4
-19.12%
-48.00K
$22.90
-$1.26M
Aug 09, 2012
203.00K
Sale
Aug 07
Form 4
163.97%
48.00K
$18.41
-$1.11M
Jan 31, 2012
77.27K
Sell-Options
Jan 27
Form 4
28.40K
Nov 18, 2011
105.68K
Grant
Nov 16
Form 4/A
12.46%
64.00K
$22.11
$2.83M
Jun 23, 2011
449.66K
Sell-Options
ScheduledJun 22
Form 4
12.46%
64.00K
$22.11
$2.83M
Jun 23, 2011
449.66K
Sell-Options
Jun 22
Form 4
77.27K
$21.61
$1.67M
Dec 21, 2010
77.27K
Acq/Dis
Dec 17
Form 4
24.39K
Nov 15, 2010
339.39K
Grant
Nov 11
Form 4
-16.89%
-32.00K
$35.24
-$1.41M
Feb 23, 2010
157.50K
Sale
Feb 19
Form 4
8.91%
18.00K
Dec 21, 2009
377.50K
Grant
Dec 17
Form 4
-2.75%
-10.67K
$24.23
-$335.47K
May 13, 2009
377.50K
Sale
May 11
Form 4
8.46%
18.00K
Nov 24, 2008
388.17K
Grant
Nov 20
Form 4
9.25%
18.00K
Nov 09, 2007
370.17K
Grant
Nov 07
Form 4
-50.00%
-157.50K
$43.21
-$6.81M
Aug 13, 2007
157.50K
Disposition
Aug 10
Form 4
-3.67%
-6.00K
$47.24
-$283.41K
Mar 12, 2007
157.50K
Sale
Mar 08 - Mar 09
Form 4
-5.22%
-9.00K
$46.61
-$419.48K
Mar 08, 2007
163.50K
Sale
Mar 06 - Mar 07
Form 4/A
3.18%
6.00K
Nov 15, 2006
367.17K
Grant
Nov 10
Form 4/A
3.18%
6.00K
Nov 14, 2006
367.17K
Grant
Nov 10
Form 4
3.18%
6.00K
Nov 14, 2006
367.17K
Grant
Nov 10
Form 4
-2.10%
-3.70K
$42.12
-$155.68K
Aug 25, 2006
172.50K
Sale
Aug 21
Form 4
10.55%
18.00K
Jul 12, 2006
364.86K
Grant
Jul 07
Form 4
8.99%
14.53K
$15.52
$225.44K
Mar 08, 2006
176.20K
Acquisition
Mar 07
Form 4
16.36%
12.00K
Jul 06, 2005
85.33K
Grant
Jul 01
Form 4
19.57%
12.00K
Jul 07, 2004
73.33K
Grant
Jul 02
Form 4
-5.83%
-5.00K
$47.46
-$237.31K
May 17, 2004
80.83K
Sale
May 13
Form 4/A
-6.12%
-4.00K
Dec 22, 2003
61.33K
Grant
Jul 07
Form 4
-7.54%
-7.00K
$41.10
-$287.72K
Aug 08, 2003
85.83K
Sale
Aug 08
Form 4
Jul 11, 2003
Showing 41 results

Imunon, Inc.

Investor
Updated Feb 23, 2010
Form 4
29.18%
25.00K
$2.94
$73.50K
Feb 23, 2010
110.68K
Grant
Feb 19
Form 4
41.20%
25.00K
$2.72
$68.00K
Feb 09, 2009
85.68K
Grant
Jan 19
Form 4
78.06%
19.01K
$2.50
$47.51K
Dec 05, 2008
43.36K
Purchase
Dec 04
Form 4
28.40%
25.00K
$5.47
$136.75K
Apr 29, 2008
113.02K
Grant
Mar 15
Form 4
19.66%
4.00K
$6.27
$25.08K
Feb 27, 2008
24.35K
Purchase
Feb 26
Form 4
10.90%
2.00K
$6.17
$12.34K
Feb 27, 2008
20.35K
Purchase
Feb 25
Form 4
234.17%
25.00K
Mar 26, 2007
35.68K
Grant
Mar 22
Form 4
52.51%
3.68K
Mar 16, 2006
10.68K
Grant
Mar 15
Form 4
110.00%
55.00K
Feb 24, 2005
105.00K
Grant
Feb 22
Form 4
18.35K
Dec 23, 2003
18.35K
Grant
Dec 22
Showing 10 results